Axer-Siegel R - Search Results

1

The Effectiveness of Intravitreal Ranibizumab in Patients with Diabetic Macular Edema Who Have Failed to Respond to Intravitreal Bevacizumab.

Ehrlich R, Dan I, Deitch I, Axer-Siegel R, Mimouni K. Ehrlich R, et al. Among authors: axer siegel r. Ophthalmologica. 2016;235(3):133-6. doi: 10.1159/000444103. Epub 2016 Mar 1. Ophthalmologica. 2016. PMID: 26926483

2

Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration.

Ron Y, Ehrlich R, Axer-Siegel R, Rosenblatt I, Weinberger D. Ron Y, et al. Ophthalmologica. 2007;221(1):57-61. doi: 10.1159/000096524. Ophthalmologica. 2007. PMID: 17183203

3

Outcome of bevacizumab (Avastin) injection in patients with age-related macular degeneration and low visual acuity.

Ehrlich R, Weinberger D, Priel E, Axer-Siegel R. Ehrlich R, et al. Retina. 2008 Oct;28(9):1302-7. doi: 10.1097/IAE.0b013e3181803c2a. Retina. 2008. PMID: 18664935

4

Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma.

Hasanreisoglu M, Weinberger D, Mimouni K, Luski M, Bourla D, Kramer M, Robinson A, Axer-Siegel R. Hasanreisoglu M, et al. Eur J Ophthalmol. 2009 Jul-Aug;19(4):607-12. doi: 10.1177/112067210901900414. Eur J Ophthalmol. 2009. PMID: 19551676

5

Photodynamic therapy for choroidal neovascularization in young adult patients.

Ehrlich R, Kramer M, Rosenblatt I, Weinberger D, Mimouni K, Priel E, Axer-Siegel R. Ehrlich R, et al. Int Ophthalmol. 2010 Aug;30(4):345-51. doi: 10.1007/s10792-010-9346-3. Epub 2010 Feb 2. Int Ophthalmol. 2010. PMID: 20127140

6

Intravitreous bevacizumab treatment for macular edema due to central retinal vein occlusion.

Axer-Siegel R, Dotan A, Mimouni K, Bor E, Weinberger D, Bourla DH. Axer-Siegel R, et al. Curr Eye Res. 2012 Sep;37(9):818-22. doi: 10.3109/02713683.2012.678543. Epub 2012 Jun 5. Curr Eye Res. 2012. PMID: 22668313

7

Intravitreal bevacizumab treatment for exudative age-related macular degeneration with good visual acuity.

Axer-Siegel R, Bor E, Bourla DH, Weinberger D, Mimouni K. Axer-Siegel R, et al. Retina. 2012 Oct;32(9):1811-20. doi: 10.1097/IAE.0b013e31825db771. Retina. 2012. PMID: 22825407

8

Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patterns.

Axer-Siegel R, Ehrlich R, Yassur Y, Rosenblatt I, Kramer M, Priel E, Benjamini Y, Weinberger D. Axer-Siegel R, et al. Am J Ophthalmol. 2004 Feb;137(2):258-64. doi: 10.1016/j.ajo.2003.08.009. Am J Ophthalmol. 2004. PMID: 14962414

9

Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.

Axer-Siegel R, Ehrlich R, Rosenblatt I, Kramer M, Priel E, Yassur Y, Weinberger D. Axer-Siegel R, et al. Arch Ophthalmol. 2004 Apr;122(4):453-9. doi: 10.1001/archopht.122.4.453. Arch Ophthalmol. 2004. PMID: 15078661

10

Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.

Axer-Siegel R, Ehrlich R, Weinberger D, Rosenblatt I, Shani L, Yassur Y, Priel E, Kramer M. Axer-Siegel R, et al. Am J Ophthalmol. 2004 Oct;138(4):602-7. doi: 10.1016/j.ajo.2004.05.074. Am J Ophthalmol. 2004. PMID: 15488787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters